Codexis Reports Third Quarter 2018 Financial Results
November 08, 2018 16:05 ET
|
Codexis, Inc.
Total revenues increase 70% to $16.9 million driven by higher product revenue and R&D revenue across an increased number of customers Conference call begins at 4:30 p.m. Eastern time today ...
Codexis Announces Results of Phase 1a Clinical Trial with CDX-6114
November 08, 2018 07:00 ET
|
Codexis, Inc.
CDX-6114 meets safety and tolerability endpoints REDWOOD CITY, Calif., Nov. 08, 2018 (GLOBE NEWSWIRE) -- Codexis, Inc. (NASDAQ: CDXS), a leading protein engineering company, announces top-line...
Codexis to Present at Two Investment Conferences in November
November 07, 2018 16:05 ET
|
Codexis, Inc.
REDWOOD CITY, Calif., Nov. 07, 2018 (GLOBE NEWSWIRE) -- Codexis, Inc. (NASDAQ: CDXS), a leading protein engineering company, announces that management will present at two upcoming investment...
Codexis Doses First Subjects in Phase 1a Trial of CDX-6114
July 09, 2018 08:00 ET
|
Codexis, Inc.
REDWOOD CITY, Calif., July 09, 2018 (GLOBE NEWSWIRE) -- Codexis, Inc. (NASDAQ:CDXS), a leading protein engineering company, announces that it has dosed the first subjects in a first-in-human Phase...
Codexis to Hold 2017 Fourth Quarter and Full Year Conference Call on March 8
March 01, 2018 07:00 ET
|
Codexis, Inc.
REDWOOD CITY, Calif., March 01, 2018 (GLOBE NEWSWIRE) -- Codexis, Inc. (NASDAQ:CDXS), a leading protein engineering company, announces that it will report fourth quarter and full year 2017 financial...
Codexis Appoints Molecular Diagnostics Industry Veteran Shawn Clairmont to Lead High-Performance Enzymes Commercialization
February 15, 2018 07:00 ET
|
Codexis, Inc.
REDWOOD CITY, Calif., Feb. 15, 2018 (GLOBE NEWSWIRE) -- Codexis, Inc. (NASDAQ:CDXS), a leading protein engineering company, announces the appointment of Shawn Clairmont to the newly created position...
Codexis to Present at the 25th International Molecular Medicine Tri-Conference
February 12, 2018 07:00 ET
|
Codexis, Inc.
REDWOOD CITY, Calif., Feb. 12, 2018 (GLOBE NEWSWIRE) -- Codexis, Inc. (NASDAQ:CDXS), a leading protein engineering company, announces that John Nicols, President & CEO, will discuss the...
Codexis Reports Financial Results for the Second Quarter of 2017
August 09, 2017 16:05 ET
|
Codexis, Inc.
Product sales more than doubled versus prior-year second quarter Affirms 2017 total revenue guidance; increases full year product sales and gross margin guidance Conference call begins at 4:30 pm...
Codexis to Hold 2017 Second Quarter Conference Call on August 9
August 02, 2017 07:00 ET
|
Codexis, Inc.
REDWOOD CITY, Calif., Aug. 02, 2017 (GLOBE NEWSWIRE) -- Codexis, Inc. (NASDAQ:CDXS), a leading protein engineering company, announces that it will report second quarter 2017 financial results after...
Codexis to Present at Two Upcoming Investment Conferences
May 30, 2017 07:00 ET
|
Codexis, Inc.
REDWOOD CITY, Calif., May 30, 2017 (GLOBE NEWSWIRE) -- Codexis, Inc. (NASDAQ:CDXS), a leading protein engineering company, announces that management will present at two upcoming investment...